Announcement • Jun 29
Maxgrow India Limited Announces Appointment of M Krishnan as Additional Non-Executive Independent Director, Effective June 29, 2026 Maxgrow India Limited had at its meeting held on June 29, 2026, approved the appointment of Dr. M Krishnan as an Additional Director under the category of Non-Executive Independent Director of the Company with effect from June 29, 2026. Dr. M Krishnan has been appointed in terms of the applicable provisions of Companies Act, 2013, and Listing Regulations, and he has confirmed that he is not debarred from holding the office of Directors pursuant to any SEBI order or any other such authority. Appointment of Dr. M Krishnan (DIN:07034128) as an Additional Non-Executive Director in the category of Independent Director of the Company. His appointment shall be subject to the approval of shareholders at the next General Meeting of the Company or within three months from the date of his appointment, whichever is earlier, and shall not be liable to retire by rotation. Dr. M Krishnan is having a total of 37 years of rich experience in the field of Indian and International Banking (Hong Kong), including more than 20 years of large corporate banking exposure in India and 4 years of international banking exposure in Hong Kong with Canara Bank, one of the leading public sector banks in India, and possessing vast professional experience in different top management capacities. Announcement • May 20
Maxgrow India Limited to Report Fiscal Year 2026 Results on May 25, 2026 Maxgrow India Limited announced that they will report fiscal year 2026 results on May 25, 2026 New Risk • May 15
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 7x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹2.22b market cap, or US$23.2m). 
